Certara Executive and Leadership Team

William Feehery, the Chief Executive Officer at Certara, directs the overarching corporate strategy and global operational vision. Feehery oversees the integration of biosimulation technologies across the entire drug development lifecycle, from discovery to market access. By aligning scientific consulting services with AI-driven platforms, the Chief Executive Officer ensures that pharmaceutical partners achieve optimized clinical outcomes. This leadership role involves constant engagement with the Board to drive long-term growth and market expansion across North American and international territories. William Feehery maintains a focus on model-informed drug development to reduce risks in clinical trials. Through rigorous oversight of organizational performance, the Chief Executive Officer secures the company's position as a leader in the R&D services sector. Feehery drives innovation by fostering a culture of scientific excellence and operational efficiency, ultimately delivering value to stakeholders while advancing global health initiatives.

Faiz Mohammed, the Interim Chief Financial Officer. at Certara, directs the financial planning, reporting, and capital allocation strategies that sustain the company's growth. Mohammed oversees the fiscal health of the organization, ensuring that investments in AI-driven platforms and scientific consulting yield measurable returns. By managing financial risk and regulatory compliance, the Interim Chief Financial Officer. supports the stability of operations across the drug development lifecycle. This role involves providing the Board with accurate financial insights to guide strategic decision-making regarding market expansion and service development. Faiz Mohammed executes rigorous budget management to optimize resource distribution across global departments. Through the oversight of financial systems, the Interim Chief Financial Officer. ensures transparency and accountability in all corporate transactions. Mohammed maintains a focus on long-term financial sustainability, enabling the company to continue providing critical biosimulation technologies to the pharmaceutical industry while navigating complex economic environments and supporting ongoing research initiatives.

Martin Snyder, the President, Certara Data Sciences at Certara, directs the specialized data science division focused on leveraging advanced analytics for drug development. Snyder oversees the application of quantitative methods and statistical modeling to enhance the accuracy of clinical trial predictions. By driving the development of data-centric tools, the President, Certara Data Sciences ensures that clients gain deeper insights into drug behavior and safety profiles. This role involves collaborating with technology teams to integrate data science capabilities into the broader biosimulation platform. Martin Snyder executes strategies to scale data-driven services across international markets, supporting regulatory submissions with robust evidence. Through the management of expert data scientists, the President, Certara Data Sciences maintains the company's leadership in model-informed drug development. Snyder focuses on delivering high-impact analytical solutions that reduce the time and cost associated with bringing new therapies to market, ultimately improving patient outcomes through precise, data-backed research methodologies.

Adrian McKemey, the President, Certara Drug Development Solutions at Certara, directs the delivery of scientific consulting services across the entire drug development lifecycle. McKemey oversees the operational execution of clinical trial support, regulatory strategy, and market access initiatives. By aligning scientific expertise with client needs, the President, Certara Drug Development Solutions ensures that pharmaceutical partners navigate complex development pathways with efficiency. This role involves managing large-scale consulting engagements that utilize biosimulation to optimize drug performance. Adrian McKemey executes strategies to expand the reach of these solutions into emerging global markets. Through the coordination of multidisciplinary teams, the President, Certara Drug Development Solutions maintains high standards of service delivery for preclinical and clinical programs. McKemey focuses on translating scientific insights into actionable regulatory outcomes, directly supporting the company's mission to accelerate the availability of life-saving therapies while maintaining rigorous quality and compliance standards throughout the development process.

Chris Bouton, the Chief Technology Officer at Certara, architects the digital infrastructure and AI-driven platforms that power biosimulation capabilities. Bouton oversees the development of software tools designed to predict drug behavior throughout the preclinical and clinical phases. By integrating advanced data analytics into the drug development lifecycle, the Chief Technology Officer ensures that clients receive actionable insights for regulatory submissions. This role involves collaborating with scientific teams to translate complex biological data into scalable technological solutions. Chris Bouton drives the technical roadmap to maintain a competitive edge in the R&D services market. Through the implementation of robust software architectures, the Chief Technology Officer supports the company's mission to accelerate drug discovery. Bouton manages the engineering departments to ensure high-performance delivery of digital assets. By prioritizing innovation in machine learning and data modeling, the Chief Technology Officer directly impacts the efficiency of global pharmaceutical research programs.

Sheila Rocchio, the Chief Marketing Officer at Certara, directs global brand strategy and market positioning for the company's suite of biosimulation and consulting services. Rocchio oversees the communication of value propositions to pharmaceutical and biotechnology clients, ensuring clear articulation of the benefits of model-informed drug development. By analyzing market trends and competitive landscapes, the Chief Marketing Officer drives demand for AI-driven platforms across diverse geographic regions. This leadership role involves coordinating with sales and product teams to align messaging with the specific needs of the drug development lifecycle. Sheila Rocchio executes comprehensive marketing campaigns that highlight the impact of scientific consulting on clinical trial success. Through strategic outreach and thought leadership, the Chief Marketing Officer expands the company's footprint in the R&D services industry. Rocchio manages brand identity to reinforce the reputation of the firm as a trusted partner in regulatory submissions and market access strategies.

Rona Anhalt, the Chief Human Resources Officer at Certara, directs the talent acquisition and organizational development strategies necessary to support a global workforce of scientific and technical experts. Anhalt oversees the recruitment of specialized talent capable of advancing biosimulation and drug development solutions. By fostering a culture of innovation and professional growth, the Chief Human Resources Officer ensures that the company retains the expertise required to deliver high-quality consulting services. This role involves designing compensation structures and performance management systems that align with corporate objectives. Rona Anhalt executes initiatives to promote diversity and inclusion across all international operations. Through the implementation of robust training programs, the Chief Human Resources Officer supports the continuous development of staff involved in clinical trials and regulatory submissions. Anhalt manages the human capital strategy to ensure organizational agility in a rapidly evolving R&D services market, ultimately driving the company's ability to meet complex client demands.